Amylyx Pharmaceuticals (AMLX) Stock: Buy, Sell, or Hold?
AMLX - Amylyx Pharmaceuticals, Inc. Common Stock
$28.57
-0.46 (-1.58%)
âŧ
5d:
+3.33%
30d:
-6.65%
90d:
+55.19%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When AMLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: AMLX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: AMLX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: AMLX is currently trading at $28.57, which is considered fair relative to its 30-day fair value range of $27.15 to $31.75.
Technical Outlook: Technically, AMLX is in a strong uptrend. Immediate support is located at $26.20, while resistance sits at $30.00.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $43.00 (+50.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AMLX is in a strong uptrend. Immediate support is located at $26.20, while resistance sits at $30.00.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $43.00 (+50.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$27.15 -
$31.75
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding AMLX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.5% below Wall St target ($43.00)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$27.15 -
$31.75
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$26.20
Resistance Level
$30.00
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-26.20
Wall Street Target
$43.00
(+50.5%)
Revenue Growth (YoY)
-99.6%
Share & Embed Analysis
Last updated: October 22, 2026 10:23 PM ET
Data refreshes hourly during market hours. Next update: 11:23 PM
Data refreshes hourly during market hours. Next update: 11:23 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
29 analysts |
$207 | 60 HOLD |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 49 HOLD |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$56 | 43 HOLD |
|
AQST
Aquestive Therapeutics IâĻ |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$65 | 59 HOLD |
Advanced AMLX Option Strategies
Professional options setups generated by AI based on today's AMLX price and gamma walls.
